Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Trials in LMIC and HIC – are the standards applicable globally ?

Choosing Wisely 2022 Mumbai

17 - 18 Sep 2022

Published: 19 Sep 2022

Rating:

Save

Dr Amol Patel - INHS Asvini, Mumbai, India

Dr Amol Patel speaks to ecancer about the trials in low-middle-income countries versus high-income countries and how the standards are applied globally.

He discusses how LMIC’s standards are different in comparison to HICs.

He explores the benefits of exchanging results of trials with other healthcare professionals.

Related Videos

The Vanessa Moss Prize: celebrating research into cancer health disparities

Dr Olubukola Ayodele - University Hospitals of Leicester NHS Trust, Leicester, UK

16 Feb 2026

Innovating cancer care access for low and middle-income countries

Lacy Hubbard - Founding President and CEO, Elekta Foundation

28 Jan 2026

Prostate cancer

Dr Alison Tree - Institute of Cancer Research, London, UK

22 Jan 2025

Rectal cancer

Dr Rebecca Wong - Princess Margaret Cancer Center, Toronto, Canada

22 Jan 2025

Tele-mentoring: Impact of project ECHO

Dr Sanjeev Arora - Project ECHO, Albuquerque, USA

22 Oct 2024

Introducing oncology to undergraduate medical and allied health sciences students

Dr Soumitra Shankar Datta - Tata Medical Center, Kolkata, India

8 Dec 2023

OncoAlert Round Up for September 15-21, 2023

Dr Gil Morgan - Executive Director, OncoAlert

25 Sep 2023

OncoAlert Round Up for September 8-14, 2023

Dr Gil Morgan - Executive Director, OncoAlert

25 Sep 2023

Treating cancer in the heart of the Ukraine conflict

Dr Maryna Kartashova and Dr Susannah Stanway

22 Sep 2023

Trials in LMIC and HIC – are the standards applicable globally ?

Choosing Wisely 2022 Mumbai

Related Videos

More from ecancer